Atherosclerosis is an inflammatory disease in the vessel wall. Nicotine, a major component of cigarette smoke, is an independent risk factor for cardiovascular diseases including atherosclerosis. As an inflammatory molecule, C-reactive protein (CRP) participates in atherogenesis. Although it has been confirmed that CRP level in smoking patient is significantly higher than non-smokers and cigarette withdrawal，it is unknown whether nicotine induces CRP expression in macrophages. The present study was to observe effect of nicotine on CRP production and the related signal pathway in U937 macrophages. The results showed that nicotine significantly increased mRNA and protein expression of CRP in U937 macrophages in timeand concentration-dependent ways. Nicotinic acetylcholine receptor (nAChR) blocker hexamethonium, MEK1/2 inhibitor PD98059, p38 MAPK inhibitor SB203580 and NF-κB inhibitor PDTC almost completely abolished nicotineinduced CRP expression in mRNA and protein levels in U937 macrophages. The further study indicated that hexamethonium, PD98059, and SB203580 significantly inhibited ERK1/2 and p38 MAPK phosphorylation. These demonstrate that nicotine has ability to induce CRP expression in macrophages through nAChR-ERK1/2/p38 MAPK-NF-κB signal pathway, which contributes to better understanding of the pro-inflammatory and pro-atherosclerotic effects of nicotine in cigarette smokers.
INTRODUCTION
Cigarette smoking has been implicated in numerous diseases including atherosclerosis (Michael, 2000; Tsiara et al., 2003) . Nicotine is a predominant chemical in cigarette, and has been suspected to be a causative agent for atherosclerosis. However, the pro-atherogenic mechanism of nicotine is still largely speculative. It is known that nicotine exhibits a direct effect on vessel cells and macrophages. Nicotine stimulates the proliferation and migration of vascular smooth muscle cells (VSMCs), the production of the inflammatory mediators like COX-2, PGE 2 , TNF-α, IL-1β and iNOS, and adhesion molecule expression in endothelial cells and macrophages by activating the transcription factor NF-κB (Lau et al., 2006; Wang et al., 2004; Yoshiyama et al., 2011; Zhou et al., 2010) . These effects of nicotine are fulfilled mainly through activating nicotinic acetylcholine receptor (nAChR) (Lee and Cooke, 2011) .
Macrophages are the predominant nucleated cells differentiated from monocyte in the peritoneal fluid and tissues. It is known that macrophages reside within atherosclerotic plaques (Hansson and Hermansson, 2011) , and contribute to the pathology of atherosclerosis. They release various products including pro-inflammatory cytokines that influence other resident cells in tissues (Denis et al., 1991; Haraldsen et al., 1996; Morzycki et al., 1990) .
Among the inflammatory cytokines, C-reactive protein (CRP) has been identified as a non-specific but sensitive marker of the acute inflammatory response. CRP is not only an important predictor of cardiocerebrovascular events, but also a direct participator in the formation and development of atherosclerosis (Ridker, 2003) . CRP stimulates the proliferation and migration of VSMCs, promotes monocyte aggregation and the complement system activation, and mediates uptake of low density lipoprotein by macrophages to promote the formation of foam cells (Diaz et al., 2003; Zwaka et al., 2001 ). In addition, CRP modulates the activities and expressions of multiple factors implicated in atherogenesis, such as enhancing IL-8 expression and decreasing endothelial nitric oxide synthase expression and prostacyclin generation in human aortic endothelial cells (Kibayashi et al., 2005; Li et al., 2004; Venugopal et al., 2002; 2003) .
Our previous studies indicated that CRP is also expressed in macrophages (Li et al., 2011) . Although nicotine is recognized to evoke an inflammatory response in macrophages, there is no direct evidence to demonstrate the pro-inflammatory effect of nicotine on macrophages through CRP. Therefore, the pre-A B C D sent study was to observe effect of nicotine on CRP expression in U937 macrophages and the molecular mechanisms, particularly focusing on mitogen-activated protein kinases (MAPK)-NF-κB signal pathway.
MATERIALS AND METHODS

Reagents
Nicotine and hexamethonium used in this experiment were nicotine hydrogen tartrate salt and hexamethonium bromide, which were purchased from Sigma-Aldrich (USA). PD98059, SB203580, SP600125 and pyrrolidine dithiocarbamate (PDTC) were obtained from Sigma-Aldrich (USA). Rabbit polyclonal anti-human C-reactive protein antibody was provided by Abcam (UK). Antibodies against phospho-ERK1/2, ERK1/2, phosphop38 MAPK and p38 MAPK were from the Beyotime Institute of Biotechnology (China).
Cell culture U937 histiocytes (American Type Culture Collection) are also called resident macrophage. U937 macrophages were cultured in a 5% CO 2 atmosphere in RPMI-1640 supplemented with 10% fetal bovine serum (FBS) (Hyclone, USA), penicillin (100 U/ml) and streptomycin (100 μg/ml). The medium was changed every 1 or 2 days. When the cells were seeded into a 6-well plate at 1 × 10 6 cells/ml, the medium was changed to the serum free medium for an additional 12 h incubation to render the cells quiescent before adding the stimulus. In the experiments of inhibitors, U937 macrophages were exposed to nicotine (10 -5 M) for 12 h after pretreated with the inhibitors for 1 h.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was isolated from U937 macrophages after the treatment using RNAfast200 (Fastagen, China) according to manufacturer′s instruction. One microgram of isolated RNA from each sample was transcribed into complementary (cDNA) using oligo (dT) 18 Primer and RevertAid™ M-MuLV Reverse Transcriptase (Fermentas, Germany). The cDNA was amplified using 2 μl of each of the CRP forward primer (5′-TCG TGG AGT TCT GGG TAG ATG-3′) and reverse primer (5′-TTC GCC TTG CAC TTC ATA CTT-3′). This resulted in a 275 bp PCR product (35 amplification cycles of 94°C for 5 min, 94°C for 30 s, 61°C for 30 s, 72°C for 1 min, and 72°C for 5 min). The housekeeping gene (GAPDH) was amplified as an internal control for normalization using the forward primer (5′-GGA TTT GGT CGT ATT GGG-3′) and the reverse primer (5′-GGA AGA TGG TGA TGG GAT T-3′). This resulted in a 205 bp product (35 amplification cycles of 94°C for 5 min, 94°C for 30 s, 55°C for 30 s, 72°C for 1 min, and 72°C for 5 min). PCR products were separated on 2% agarose gels. Results were expressed as relative to control.
Western blotting
The treated cells were washed with PBS, lysed by 200 μl of icecold RIPA lysis buffer supplemented with the protease inhibitor cocktail (Roche, Germany). Protein concentration was measured by BCA protein assay kit (Pierce, USA). Equal amount of protein extract (50 μg) was loaded, separated by 10% SDS-PAGE, and blotted onto nitrocellulose membrane. Then, the membranes were incubated with rabbit polyclonal anti-CRP (1:100 dilution), anti-phospho-ERK (1:1,000 dilution), anti-ERK (1:1,000 dilution), anti-phospho-p38 MAPK (1:1,000 dilution), and anti-p38 MAPK (1:1,000 dilution), anti-beta actin (1:1,000 dilution) antibodies overnight at 4°C. After washed, the membranes were incubated with anti-rabbit or anti-mouse IgG antibody conjugated with horseradish peroxidase for 2 h at room temperature. The immunostaining was visualized by the enhanced chemiluminescence (Pierce, USA).
Statistical analysis
All values were shown as mean ± S.E.M. Statistical significance between groups was assessed by one-way ANOVA, followed by Dunnett's multiple comparison tests. A value of P < 0.05 was considered statistically significant. Figures 1A and 1C showed that nicotine at 10 Figs. 1B and 1D showed that nicotine also increased mRNA and protein expression of CRP in U937 macrophages in a time-dependent fashion. CRP expression was gradually increased, and reached the maximum 24 h after nicotine stimulation.
RESULTS
Nicotine induces CRP expression in U937 macrophages
Nicotine induces CRP expression in U937 macrophages via nAChR
To test the role of nAChR in nicotine-induced CRP expression in U937 macrophages, the cells were pretreated with nAChR blockers hexamethonium for 1 h before nicotine stimulation. The results showed that hexamethonium abolished nicotineinduced mRNA and protein expression of CRP in U937 macrophages ( Figs. 2A and 2B ).
Nicotine induces CRP expression in U937 macrophages through nAChR-MAPK signal pathway
Following stimulation of U937 macrophages with 10 -5 M nicotine for 12 h, mRNA and protein expression of CRP was signify- -5 M) for 1 h prior to stimulation with nicotine (10 -5 M, Nic) for 12 h. Then, mRNA level (A) and protein expression (B) of CRP were analyzed by RT-PCR and Western blot, respectively. Data from three independent experiments are expressed as means ± S.E.M. **P < 0.01 and ***P < 0.001 vs. nicotine alone. The above-mentioned results indicate that nAChR, p38 MAPK and ERK1/2 participate in nicotine-induced CRP expression in U937 macrophages. To elucidate whether nAChR mediated nicotine-induced activation of p38 MAPK and ERK1/2 in U937 macrophages, the phosphorylated p38 MAPK and ERK1/2 were determined. Western blot analysis revealed that a marked increase of the phosphorylated p38 MAPK and ERK1/2 was detected following stimulation of the cells with nicotine. However, pretreatment of the cells with hexamethonium and PD98059 or SB203580 for 1 h prior to exposure of the cells to nicotine markedly inhibited nicotine-induced phosphorylation of p38 MAPK and ERK1/2 (Figs. 4A and 4B ).
DISCUSSION
Epidemiological evidence demonstrates that cigarette smoking increases the incidence of cardiovascular diseases. Even though nicotine has been widely accepted as a risk factor for atherosclerosis (Ambrose and Barua, 2004) , it is not completely known how nicotine contributes to atherosclerosis. Some investigators have provided evidence that nicotine promotes inflammation (Furie et al., 2000; Tottiet et al., 1984) . By contrast, other studies indicate that nicotine produces an immunosuppressive effect in relatively high doses (Matsunaga et al., 2001) .
Early studies demonstrated that nicotine induces production of various inflammatory mediators which are known to be an initial event of atherosclerotic pathogenesis (Lau et al., 2006; Wang et al., 2004) . As the main inflammatory cells, monocytes and monocyte-derived macrophages have been recognized as the cellular hallmark of atherosclerosis (Rogacev et al., 2010) . Monocytes are recruited to the vascular wall during the process of atherogenesis where they differentiate into macrophages and acquire the capacity to synthesize an array of cytokines, chemokines and growth factors, which contribute to the development of atherosclerosis (Wang et al., 2008) .
As a representative marker of the inflammatory response, CRP participates in all stages of atherosclerotic process, and provides a pivotal link between inflammation and atherogenesis (Kaperonis et al., 2006) . Although the elevated serum level of CRP is predominately produced by hepatocytes, other types of cells such as VSMCs, vascular endothelial cells (VECs) and macrophages may secrete CRP (Ciubotaru et al., 2005; Han et al., 2010; Peng et al., 2007) . Moreover, the locally produced CRP in the vessel wall may play a direct and essential role in the whole inflammatory process of atherosclerosis and the development of cardiovascular complications. The present results showed that nicotine stimulated mRNA and protein expression of CRP in U937 macrophages. The nicotine concentrations used in the experiment were 10 -8 -10
-4 M, which were approximately in accordance with the plasma levels of smokers (10 -8 -
10
-5 M) (Benowitz, 1996) . Therefore, the results demonstrate that nicotine produces a pro-inflammatory effect through stimulating CRP expression in U937 macrophages.
nAChR is widely distributed throughout the nervous system and other non-neuronal cells such as monocytes, endothelial cells, and epithelial cells (Conti-Fine et al., 2000; Davies et al., 1982; Macklin et al., 1998; Wang et al., 2001) . Nicotine may activate nAChR. Therefore, nAChR possibly mediates the proinflammatory effect of nicotine on macrophages. In the present experiment, pretreatment of U937 macrophages with hexamethonium (a non-selective nAChR blocker) almost completely abolished nicotine-induced CRP increase in mRNA and protein levels, suggesting that nicotine induces CRP expression in macrophages via nAChR.
A great number of investigations document that the MAPK family members (p38 MAPK, JNK and ERK) are important in regulating the production of inflammatory cytokines and mediators (Sun et al., 2008) . In this study, we found that MEK1/2 inhibitor PD98059 and p38 MAPK inhibitor SB203580 substantially reduced nicotine-induced mRNA and protein expression of CRP in U937 macrophages, while JNK inhibitor SP600125 had no significant effect on CRP expression, implicating that nicotine-induced CRP expression in U937 macrophages depends on ERK1/2 and p38 MAPK signaling. This finding is consistent with our previous results that angiotensin II induces CRP expression through ERK1/2 and p38 MAPK signal pathway in U937 macrophages (Li et al., 2011) . In addition, we also found that nAChR antagonist hexamethonium inhibited nicotineinduced phosphorylation of ERK1/2 and p38 MAPK in U937 macrophages, certifying that nicotine activates phosphorylation of ERK1/2 and p38 MAPK through nAChR, and ERK1/2 and p38 MAPK are the downstream molecules of nAChR.
As a major transcription factor in inflammatory response, NF- Fig. 4 . Nicotine induces CRP expression in U937 macrophages through nAChR-MAPK signal pathway. The cells were stimulated with nicotine (10 -5 M) for 1 h after pretreated with hexamethonium (10 -5 M), SB203580 (p38 MAPK inhibitor, 10 µM) or PD098059 (MEK1/2 inhibitor, 20 µM) for 1 h. Then, expressions of ERK1/2 and p38 MAPK, phosphorylated ERK1/2 and p38 MAPK were measured by Western blot. Data from three independent experiments are expressed as the mean ± S.E.M. ***P < 0.001 vs. nicotine alone.
κB is considered to be a downstream molecule of MAPK. Nicotine is able to promote NF-κB activation in macrophages and VECs (Lau et al., 2006; Zhou et al., 2010) . Our result exhibited that NF-κB was involved in nicotine-induced CRP expression in U937 macrophages, since the selective NF-κB inhibitor PDTC completely blocked CRP expression in response to nicotine.
In summary, these data demonstrate that nicotine induces CRP expression in macrophages via nAChR-ERK1/2/p38 MAPK-NF-κB signal pathway, which contributes to better understanding of the pro-inflammatory and pro-atherosclerotic effects of nicotine in cigarette smokers.
